Kailera Therapeutics IPO
Kailera Therapeutics IPO Pages
Kailera Therapeutics Share Price
Updated 16 Jun 2026, 20:00 UTCMarket price is delayed up to ~15 minutes, shown for information only — not investment advice.
Key Dates
About Kailera Therapeutics
Kailera Therapeutics is a biopharmaceutical company developing oral and injectable therapies targeting obesity, cardiometabolic disease and related chronic conditions. The company has multiple clinical-stage assets in its pipeline.
IPO Details
- Type
- Mainboard
- Exchange
- Nasdaq
- Country
- United States
- Sector
- Healthcare & Pharma
- Registrar
- KFin Technologies
- Regulator
- SEC
- Promoter Holding
- 58.7%
Frequently Asked Questions
What is the price band of Kailera Therapeutics IPO?
The price band of Kailera Therapeutics IPO is $16–$16 per share.
When does Kailera Therapeutics IPO open and close?
Kailera Therapeutics IPO opens on 14 Apr 2026 and closes on 16 Apr 2026.
When will Kailera Therapeutics IPO be listed?
Kailera Therapeutics IPO is expected to list on 17 Apr 2026 on Nasdaq.
Who is the registrar for Kailera Therapeutics IPO?
KFin Technologies is the registrar for Kailera Therapeutics IPO. You can check allotment status on their official portal using your PAN or application number.
What is the issue size of Kailera Therapeutics IPO?
The total issue size of Kailera Therapeutics IPO is $625 million.